A successful management with electroconvulsive therapy of neuroleptic malignant syndrome due to amisulpride
Full Text (PDF)
Ali Karayağmurlu 1 * , Elif Karayağmurlu 2, Mehmet Fatih Üstündağ 3, Ece Yazla 4
More Detail
1 Department of Child and Adolescent Psychiatry, Gaziantep Child State Hospital, Gaziantep, Turkey2 Department of Psychiatry, Gaziantep University, Faculty of Medicine, Gaziantep, Turkey3 Erenköy Training and Research Hospital for Psychiatric and Neurological Diseases, Department of Psychiatry, İstanbul, Turkey4 Department of Psychiatry, Hitit University, Faculty of Medicine, Çorum, Turkey* Corresponding Author

Abstract

Neuroleptic malignant syndrome is a severe complication that mainly occurs based on neuroleptic drug treatment and characterized with some autonomic symptoms, altered mental state, hyperthermia and muscle rigidity. Amisulpride is a unique atypical antipsychotic that selectively blocks D2 and D3 receptors presynaptically in the frontal cortex and atypical antipsychotics are rarely caused neuroleptic malignant syndrome(NMS).This study examine a 20-years old male with the diagnosis of acute psychotic disorder occurred amisulpride-induced NMS and successfully treated with Electroconvulsive Therapy (ECT). We decided to present that case because of the fact that there is only limited number of amisulpride-induced NMS cases reported in the literature.

Keywords

License

This is an open access article distributed under the Creative Commons Attribution License which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Article Type: Case Report

ELECTRON J GEN MED, Volume 15, Issue 3, June 2018, Article No: em14

https://doi.org/10.29333/ejgm/83617

Publication date: 13 Feb 2018

Online publication date: 14 Feb 2018

Article Views: 2437

Article Downloads: 1372

Open Access Disclosures References How to cite this article